Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

BACKGROUND: Androgen receptor (AR) is widely expressed in breast cancer (BC) but its role in estrogen receptor (ER)-positive tumors is still controversial. The AR/ER ratio has been reported to impact prognosis and response to antiestrogen endocrine therapy (ET). METHODS: We assessed whether AR in pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Puccetti, Maurizio, Tumedei, Maria Maddalena, Scarpi, Emanuela, Andreis, Daniele, Maltoni, Roberta, Sarti, Samanta, Cecconetto, Lorenzo, Fedeli, Anna, Pietri, Elisabetta, De Simone, Valeria, Asioli, Silvia, Amadori, Dino, Bravaccini, Sara
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5872575/
https://ncbi.nlm.nih.gov/pubmed/29587674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4239-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars